Pharmacological alteration of sleep and dreamsa clinical framework for utilizing the electrophysiological and sleep stage effects of psychoactive medications

Human Psychopharmacology

Volumn 11, Issue 3, 1996, Pages 217-223

  Pagel, J F ^a  

^a Parkview Neurological Institute   (United States)

Author keywords

Dreams; Electrophysiology; Neuropharmacology; Parasomnia; Sleep

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; AMPHETAMINE DERIVATIVE; ANTIHISTAMINIC AGENT; BUSPIRONE; CLONAZEPAM; DIAZEPAM; DOXEPIN; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; MAPROTILINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; PSYCHOTROPIC AGENT; QUAZEPAM; SERTRALINE; TEMAZEPAM; TRANYLCYPROMINE; TRIAZOLAM; TRIMIPRAMINE; VENLAFAXINE; ZOLPIDEM;

ARTICLE; DEPRESSION; DREAMING; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; PRIORITY JOURNAL; REM SLEEP; SLEEP PATTERN; SLEEP WAKING CYCLE;

EID: 0029680502     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199605)11:3<217::AID-HUP790>3.0.CO;2-0     Document Type: Article

References (40)

1. REFERENCES Abramowiez, M. (Ed.), (1986). Drugs for psychiatric disorders. Medical Letters, 38(725), 99-104.
2. Azumi, K., Shirakawa, S. and OgiuivM. ,(1981), Hypnotic drugs and spindle analysis. In: Psyekophysiological Aspects of Sleep, Jiawpan, I. (Ed.), Noyés Medical Publications, Park Ridge, New Jersey, pp. 139-153.
3. Bearden, C. (1994). The nightmare: Biological and psychological origins. Dreaming, 4(2), 1,39-152,
4. Besset, A., Tafti, M., Barthouil, P., Rbssi, P. and Billard, M. (1990). Eiïect of zolpideiq 10 mg an sleep architecture aad daytime psychomdtor skills in poor sleepers. Sleep Research, 19, 54.
5. Broughton, R. J. (1968). Sleep disorders: Disorders of arousal? Science, 159(819), 1070-1078.
6. Butter, M., Ivfaitre, P. O., Crevoisier, C. aad Stanski, D. R. (1990). Electroencephalagraphlc effects of benzodiazepin'es. II. Pharmacodynamic modeling of the electroence.phalographic effects of midazolam and depam. Clinical .'Pharmaeolagy- and, Therapeutics, 48(5), 553-567.
7. Coenfïi, A. M, L- Wd vftn Lurjtelaw, p. L. J. M. (1991). Phamiacologipal dissociation of EEG; and behavior: A',basic prtjiiern in sleepvake classification. Sleep, 14(5), 464-4:65.
8. Craib A. R. and Perry, M. M. (1975). Medication and drug effects on the EEG. In: EEG:Handbook, Low, M. D. (Ed.), Beckman Instruments Inc., Vancouver, lip. 9(2-8).
9. Delgado, P. L. and Charney, D. S. (1992). Neurochemistry of affective disorders. In: Handbook of Affective Disorders, Paykel, E. S. (Ed.), Churchill Livingstone Inc., New York, New York, pp. 219-253.
10. Delgado, P. L., Price, I. EL, Miller, H. L., Salomon, R. M., Aghajanian, G. K., Heninger, G. R. and Charney, D. S. (1994). Serotonin and the neurobiology of depression. Archives of General Psychiatry, 51, 865-874,
11. Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G. Langer S.Z. and Bartholmi, G. (1986). Zolpidem, a novel nonbenzodiazepine hypnotic. I. Nuropharmacological and behavioral effects. Journal of Pharmaclogy and Experimental Therapeutics, 237(2), 649-658.
12. Ferini-Strambi, L., Minicucci, F., Franceschi, M., Pinto, P., Bettinelli, A., Bonollo, L., Martini, A. and Smirne, S. (1987). Effects of shorts term treatment with befuraline on sleep and REM-inducing activity of physostigmiNe. Current Therapeutic Research, 41(1), 48-57.
13. Fink, ?. An objective classification of psychoactive drugs. Progress in Neuropsychopharmacology, 4, 495-502.
14. Gillin, J. C. and Byerley, W. F. (1990). The diagnosis and management of insomnia. New England Journal of Medicine, 332(4), 239-248.
15. Hart, L. L., Middleton, R. K. and Schott, W. J. (1989). Drug treatment for sleep apnea. Drug Intelligence and Clinical Pharmacology, An Pharmacotherapy, 23, 308-315.
16. Hartmann, E. (1984). The Nightmare: The Psychology and Biology of Frightening Dreams. Basic Books, New York.
17. Herrmann, W. M. (1982). Development and critical evaluation of an objective procedure for the électroencéphalographie classification of psychotrophic drugs. In: Electroencephalography in Drug Research, Herrmann, W. M. (Ed.), Gustav Fisher, Stuttgart, pp. 249-351.
18. Herrmann, W. M. and Schaerer, E. (1986). PharmacoEEG: Computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In: Clinical Applications of Computer Analysis of EEG and other Neurophysiological Signals, EEG Handbook (revised series), Vol. 2, Lopes et al. (Eds), Eisevier, Amsterdam, pp. 385-445.
19. Hobson, J. A. (1988). The Dreaming Brain. Basic Books, New York.
20. Itil, T. M. (1981). The discovery of psychotrophic drugs by computer-analyzed cerebral bioelectrical potentials (CEEG). Drug Development and Research, 1, 373-407.
21. Javanoviv, U. J. (1974). Rating scale for drug effects on sleep electroencephalograms. Ten categories of psychopharmacological agents. In: Psychotrophic Drugs and the Human EEG, Itil, T. M. (Ed.), S. Karger AG, Basel, pp. 158-181.
22. Kupfer, D. J. (1988). Advances in sleep and EEG research. In: Psycobiology and Psychopharmacology, Flach, F. (Ed.), W. W. Norton and Co., New York, pp. 213-232.
23. Kupfer, D. J., Ehlers, C. L., Frank E., Grochocinski, V.J., MeEachran, A. B. and Buhari, A. (1994). Resistant effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biological Psychiatry, 35, 781-793.
24. Lader, M. (1992). Rebound insomnia and newer hypnotics. Psychopharmacology, 108, 248-255.
25. Mandema, J. W. and Danhof, M. (1992). Electroencephalogram effect measures and relationships between pharamacokinetics and pharmacodynamics of centrally acting drugs. Clinical Pharmacokinetics, 23(3), 191-215.
26. Mendelson, W. B. (1992). Neuropharmacology of sleepinduction by 2 benzodiazepines. Clinical Reviews in Neurobiology, 16(4), 221-232.
27. Pagel, J. F. (1989). Nightmares. AFP, 39(3), 145-148.
28. Pagel, J. F. (1993). Modelling drug actions on electrophysiologic effects produced by EEG modulated potentials. Human Psychopharmacology, 8, 211-216.
29. Pagel, J. F. (1994). The treatment of insomnia. American Family Physician, 49(6), 1417-1422.
30. Reite, M. L., Nagel, K. E. and Ruddy, J. R. (1990). The Evaluation and Management of Sleep Disorders, American Psychiatrie Press, Washington D.C.
31. Reynolds, C. and Kupfer, D. (1987). Sleep research in affective illness: State of the art circa 1987. Sleep, 10, 199-215.
32. Rickeis, K., Schweizer, E., Clary, C., Fox, I. and Weise, C. (1994). Nefazodone and imipramine in major depression: A placebo-controlled trial. British Journal of Psychiatry, 164, 802-805.
33. Saletu, B., Frey, R., Krupka, N., Anderer, P., Grunberger, J. and See, W. R. (1991). Sleep laboratory studies on the single-dose effects of seratonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep, 14(5), 439-447.
34. Saletu, B., Grunberger, J., Anderer, P., Linzmayer, L., Semlitsch, H. V. and Magni, G. (1992). Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology. British Journal of Clinical Pharmacology, 33, 589-601.
35. Saito, M., Kita, S. and Kagono, Y. (1982). The orientation of psychotropic drug properties based on the induced changes in 2 electroencephalogram. Studies on zimelidine and sulpiride. In: Electroencephalography in Drug Research, Herrman, W. M. (Ed.), Gustav Fisher, Stuttgart, pp. 51-74.
36. Sussman, N. (1995). Neurochemistry of serotonin and depression. Primary Psychiatry, 2(3), 28-33.
37. Terzano, M. G. and Parrino, L. (1992). Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with zolpidem. Sleep, 15(1), 64-70.
38. Thorpy, M. J. (Ed.) (1990). The International Classification of Sleep Disorders: Diagnosis and Coding Manual. Produced by the American Sleep Disorders Association, Alien Press Inc., Lawrence, Kansas.
39. Ware, J. C., Brown, F. W, Moorad, P. J., Pittard, J. T. and Cobert, B. (1989). Effects on sleep: A doubleblind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep, 12(6), 537-549.
40. Ware, J. C., Rose, F. V. and McBrayer, R. H. (1994). The acute effects of nefazodone, trazadone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep, 176, 544-550.